지원사업
학술연구/단체지원/교육 등 연구자 활동을 지속하도록 DBpia가 지원하고 있어요.
커뮤니티
연구자들이 자신의 연구와 전문성을 널리 알리고, 새로운 협력의 기회를 만들 수 있는 네트워킹 공간이에요.
논문 기본 정보
- 자료유형
- 학술저널
- 저자정보
- 저널정보
- 대한외과학회 Annals of Surgical Treatment and Research Annals of Surgical Treatment and Research Vol.107 No.3
- 발행연도
- 2024.9
- 수록면
- 167 - 177 (11page)
이용수
초록· 키워드
오류제보하기
Purpose: This study aimed to describe adult living donor liver transplantation (LDLT) for acute liver failure and evaluate its clinical significance by comparing its surgical and survival outcomes with those of deceased donor liver transplantation (DDLT).
Methods: We retrospectively reviewed the medical records of 267 consecutive patients (161 LDLT recipients and 106 DDLT recipients) aged 18 years or older who underwent liver transplantation between January 2006 and December 2020.
Results: The mean periods from hepatic encephalopathy to liver transplantation were 5.85 days and 8.35 days for LDLT and DDLT, respectively (P = 0.091). Among these patients, 121 (45.3%) had grade III or IV hepatic encephalopathy (living, 34.8%vs. deceased, 61.3%; P < 0.001), and 38 (14.2%) had brain edema (living, 16.1% vs. deceased, 11.3%; P = 0.269) before liver transplantation. There were no significant differences in in-hospital mortality (living, 11.8% vs. deceased, 15.1%; P = 0.435), 10-year overall survival (living, 90.8% vs. deceased, 84.0%; P = 0.096), and graft survival (living, 83.5% vs. deceased, 71.3%; P = 0.051). However, postoperatively, the mean intensive care unit stay was shorter in the LDLT group (5.0 days vs. 9.5 days, P < 0.001). In-hospital mortality was associated with vasopressor use (odds ratio [OR], 3.40; 95% confidence interval [CI], 1.45–7.96; P = 0.005) and brain edema (OR, 2.75; 95% CI, 1.16–6.52; P = 0.022) of recipient at the time of transplantation. However, LDLT (OR, 1.26; 95% CI, 0.59–2.66; P = 0.553) was not independently associated with in-hospital mortality.
Conclusion: LDLT is feasible for acute liver failure when organs from deceased donors are not available.
Methods: We retrospectively reviewed the medical records of 267 consecutive patients (161 LDLT recipients and 106 DDLT recipients) aged 18 years or older who underwent liver transplantation between January 2006 and December 2020.
Results: The mean periods from hepatic encephalopathy to liver transplantation were 5.85 days and 8.35 days for LDLT and DDLT, respectively (P = 0.091). Among these patients, 121 (45.3%) had grade III or IV hepatic encephalopathy (living, 34.8%vs. deceased, 61.3%; P < 0.001), and 38 (14.2%) had brain edema (living, 16.1% vs. deceased, 11.3%; P = 0.269) before liver transplantation. There were no significant differences in in-hospital mortality (living, 11.8% vs. deceased, 15.1%; P = 0.435), 10-year overall survival (living, 90.8% vs. deceased, 84.0%; P = 0.096), and graft survival (living, 83.5% vs. deceased, 71.3%; P = 0.051). However, postoperatively, the mean intensive care unit stay was shorter in the LDLT group (5.0 days vs. 9.5 days, P < 0.001). In-hospital mortality was associated with vasopressor use (odds ratio [OR], 3.40; 95% confidence interval [CI], 1.45–7.96; P = 0.005) and brain edema (OR, 2.75; 95% CI, 1.16–6.52; P = 0.022) of recipient at the time of transplantation. However, LDLT (OR, 1.26; 95% CI, 0.59–2.66; P = 0.553) was not independently associated with in-hospital mortality.
Conclusion: LDLT is feasible for acute liver failure when organs from deceased donors are not available.
목차
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES
참고문헌 (0)
참고문헌 신청함께 읽어보면 좋을 논문
논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!
-
Outcome of deceased donor liver transplantation for alcoholic liver disease
한국간담췌외과학회 학술대회지
2016 .04
-
생체간이식에 관한 공여자 합병증
Clinical Transplantation and Research
2017 .01
-
Outcomes of deceased donor liver transplantation from elderly donors
Annals of Hepato-Biliary-Pancreatic Surgery
2021 .12
-
Liver transplantation for hepatocellular carcinoma from living-donor vs. deceased donor
Annals of Hepato-Biliary-Pancreatic Surgery
2022 .12
-
Increased survival in hepatitis c patients who underwent living donor liver transplant: a case-control study with propensity score matching
Annals of Surgical Treatment and Research
2017 .12
-
Clinical outcome of 1,000 consecutive cases of liver transplantation : a single center experience
Annals of Surgical Treatment and Research
2018 .11
-
The impact of MELD score on deceased donor liver transplant outcomes in low volume liver transplantation center: A retrospective and single center study
Annals of Hepato-Biliary-Pancreatic Surgery
2022 .12
-
Early use of everolimus improved renal function after adult deceased donor liver transplantation
Annals of Hepato-Biliary-Pancreatic Surgery
2021 .12
-
Early experiences of liver transplantation in new opened hospital
Annals of Hepato-Biliary-Pancreatic Surgery
2022 .12
-
[Vascular Surgery / Transplantation] Long-term Clinical Outcomes and Predictive Factors for Living-Donor Liver Transplant Recipients with Acute Liver Failure
대한외과학회 학술대회 초록집
2022 .11
-
Implementation of a living donor liver transplantation program in the Republic of Uzbekistan: a report of the first 40 cases
Clinical Transplantation and Research
2024 .06
-
Effect of donor-specific antibodies and panel reactive antibodies in living donor liver transplant recipients
Annals of Surgical Treatment and Research
2015 .01
-
Hepatic artery reconstruction using interposition of autologous saphenous vein conduit for living donor liver transplantation: a case report
Clinical Transplantation and Research
2021 .09
-
Performance of artificial intelligence in predicting survival following deceased donor liver transplantation: Retrospective study using multi-center data from the Korean Organ Transplant Registry (KOTRY)
Annals of Hepato-Biliary-Pancreatic Surgery
2021 .12
-
Deceased donor liver transplantation in an adult recipient with situs inversus totalis: A case report of 10-year clinical sequences following primary and repeat transplantation
Annals of Hepato-Biliary-Pancreatic Surgery
2020 .08
-
Outcome of patients with severe alcoholic hepatitis after Model for End-Stage Liver Disease-based allocation system implementation in Korea
Clinical Transplantation and Research
2021 .01
-
Auxiliary liver transplantation for acute liver failure
Annals of Hepato-Biliary-Pancreatic Surgery
2021 .12
-
Living donor liver transplantation in polycystic liver disease: The recipient liver splitting method
Annals of Hepato-Biliary-Pancreatic Surgery
2022 .12
-
Biliary Complications after Living Donor Liver Transplantation Differ from Those after Deceased Donor Liver Transplantation
Gut and Liver
2022 .03
-
Long-term Survival Outocme Beyond the First Year of for Pediatric Acute Liver Failure : A Large-volume Living Donor Liver Transplantation Single Center Study
대한외과학회 학술대회 초록집
2021 .11
최근 본 자료
댓글(0)
0
UCI(KEPA) : I410-151-25-02-091059487